# Target Therapies Resistance Molecular Profiling in Patients With Neoplastic Disease

> **NCT03347318** · — · ACTIVE_NOT_RECRUITING · sponsor: **Fondazione del Piemonte per l'Oncologia** · enrollment: 2500 (estimated)

## Conditions studied

- Solid Tumors

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03347318
- **Lead sponsor:** Fondazione del Piemonte per l'Oncologia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2011-03-30
- **Primary completion:** 2026-03-15
- **Final completion:** 2026-03-31
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03347318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03347318, "Target Therapies Resistance Molecular Profiling in Patients With Neoplastic Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03347318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*